Short- and long-term outcomes of 486 consecutive laparoscopic splenectomy in a single institution
Authors:
Open Access
- 2 April 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (13) , e25308
Abstract
Since its introduction in 1991, laparoscopic splenectomy (LS) has become the gold standard in elective spleen surgery in many centres. However, there still lack the report of long-term outcomes of LS with the large-scale cases. The aim of the present study was to analyze the short- and long-term outcomes of LS in a single institution over 16 years, and to compare the perioperative outcomes of totally laparoscopic splenectomy (TLS) and hand-assisted laparoscopic splenectomy (HALS) for splenomegaly. Between November 2002 and December 2018, 486 consecutive patients undergoing elective LS were enrolled in this study, including 222 TLS and 264 HALS. The intraoperative, postoperative, and follow-up data were retrospectively analyzed. The 5 most common indications were hypersplenism (71.0%), immune thrombocytopenia (14.8%), splenic benign tumor (4.5%), splenic cyst (2.9%), and splenic malignant tumor (2.9%). The mean operative time, intraoperative blood loss, and length of stay were 149.4 ± 63.3 minutes, 230.1 ± 225.1 mL, and 6.7 ± 3.2 days, respectively. The morbidity, mortality, reoperation, and conversion rate were 23.0%, 0, 0.4%, and 1.9%, respectively. Portal vein system thrombosis (PVST) was the most frequent complication with an incidence of 19.8%. The incidence of PVST in HALS was higher than that in TLS (23.9% vs 14.9%, P = .013). Compared with TLS, HALS had a shorter operative time (P = .000), lower intraoperative blood loss (P = .000), comparable conversion rate (P = .271), and morbidity (P = .922) for splenomegaly > 17.0 cm. During the follow-up period, the overall respond rate for immune thrombocytopenia was 77.8%, and the esophagogastric variceal bleeding rate was 6.9% in 320 patients with hypersplenism secondary to hepatic cirrhosis. LS is a safe, feasible, and effective procedure with satisfactory short- and long-term outcomes. HALS is a reasonable technique in patients with massive spleens.Keywords
Funding Information
- National Natural Science Foundation of China (no.81860418)
- Key Research and Development Program of Jiangxi Province (no. 20192BBG70035)
This publication has 37 references indexed in Scilit:
- Laparoscopic splenectomy: a surgeon’s experience of 302 patients with analysis of postoperative complicationsSurgical Endoscopy, 2013
- Anterior Versus Posterolateral Approach for Total Laparoscopic Splenectomy: A Comparative StudyInternational Journal of Medical Sciences, 2013
- Hand-Assisted Laparoscopic Splenectomy Is a Better Choice for Patients with Supramassive Splenomegaly Due to Liver CirrhosisJournal of Laparoendoscopic & Advanced Surgical Techniques, 2012
- Laparoscopic splenectomy: experience of a single center in a series of 300 casesSurgical Endoscopy, 2012
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Laparoscopic accessory splenectomy: the value of perioperative localization studiesSurgical Endoscopy, 2009
- Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES)Surgical Endoscopy, 2008
- Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patientsJournal of Gastroenterology and Hepatology, 2007
- High Incidence of Thrombosis of the Portal Venous System After Laparoscopic SplenectomyAnnals of Surgery, 2005
- Hand-assisted laparoscopic splenectomy (HALS) in cases of splenomegalySurgical Endoscopy, 2001